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INTRODUCTION 
  1
INTRODUCTION 
Nutritional deficiency disorders constitute a major health problem 
in India. In addition to direct implications for morbidity and mortality 
undernutrition predisposes children and adults to various infections1. 
Three micronutrients- vitamin A, iron, and iodine are among the most 
important of all the nutrients needed by the body because they are vital 
for developing normal learning and cognitive functions, immune defence 
mechanism, work capacity, and reproductive health2. Deficiencies of 
these three micronutrients are known to have devastating effects on 
health. 
 
Anemia resulting from lack of sufficient iron for the synthesis of 
hemoglobin is the most common hematological disease of infancy and 
childhood .22.1t is estimated that 30% of the global population suffers 
from iron deficiency anemia; most of those affected live in developing 
countries.22 
 
Iron deficiency anemia occurs when iron absorption cannot 
compensate iron requirements and losses. Requirements are especially 
high in pregnant women, infants, Young children and adolescents. The 
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consequences of iron deficiency anemia are many and serious, affecting 
not only individual's health, but also the development of societies and 
countries.3 
 
Global Scenario4-7 
Iron deficiency anemia affects nearly 2 billion people around the 
world. Of these nearly 90% are in the developing countries.  
 
Indian Scenario4-7 
In India according to NFHS-3 survey, 71% of children, 32-54%  of 
adolescent girls and 49%-58% of pregnant women are affected by iron 
deficiency anemia.  5.8 - 48.8% of pregnant women are severely anemic. 
19% of maternal deaths are attributed to iron deficiency anemia alone. 
 
Tamil Nadu Scenario4-7 
In Tamil Nadu 66% of children and 42.8% of adolescent girls are 
affected by iron deficiency anemia. Though it is less than the national 
level it is definitely more than the desired level. 
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Strategies to prevent iron deficiency anemia 
The major factors responsible for iron deficiency anemia in 
developing countries are reduced intake and poor bio availability of 
dietary iron. The iron requirements in different age groups are different. 
 
WHO expert group34 proposed that anemia should be considered to 
exist when hemoglobin is below the following levels. 
Cut-off points for the diagnosis of anemia 
 Gm/dl (venous blood) 
Adult males 13 
Adult females, Non-pregnant 12 
Adult females, Pregnant 11 
Children, 6months to 6 years 11 
Children, 6years to 14 years 12 
 
Different interventions are needed for the prevention and the 
control of iron deficiency. Iron fortification of staple foods or condiments 
directed to the whole population is a sustainable and cost-effective 
approach. However, at some periods of life, especially during pregnancy 
and in children from the age of 6 months, iron requirements are high. For 
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pregnant women, the current. approach favours the daily iron-folate 
supplementation during pregnancy but the results in terms of public 
health are disappointing 3. 
 
For infants and young children, iron fortification of complementary 
food is effective but it is economically inaccessible to populations with 
limited resources. When complementary foods are not available, the 
preventive iron supplementation from 6 to 18 months of age has to be 
advised. These, interventions are more effective when they integrate other 
approaches like the improvement of the nutritional practices, infection 
control and the promotion of breast-feeding and when coupled with 
programs aiming to control other micronutrient deficiencies. The success 
of most interventions requires the active participation of the individuals.3 
 
Information and education of the populations, especially through 
social mobilization campaigns, are essential because iron deficiency 
induces few visible symptoms, not easily recognizable by individuals. 
The implementation of national nutrition plans including the control of 
iron deficiency as one of the priorities and the participation of the public 
health, and education sectors, food industries; the community and the 
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media should contribute to the success of the interventions and to the 
control of iron deficiency. 
 
 The Government of India has initiated a number of Programmes in 
the country to improve the health and the nutritional status of the 
population. 
 
National Nutritional Anemia Prophylaxis Programme1  
To control iron deficiency anemia the National Nutritional Anemia 
Prophylaxis Programme (NNAPP) was launched in 1970 with the main 
intervention of distribution of iron and folic acid tablets to expectant 
mothers and children. 
 
Ante-natal mothers were given 60 mg of iron and 500 mcg of folic 
acid in the 100 days of pregnancy and children were given a tablet 20 mg 
of elemental iron and 100 mcg folic acid. 
 
It has been shown that NNAPP did not have the desired impact on 
anemia prevalence. A multicentric study by Indian Council of Medical 
Research revealed that 17% of pregnant women had hemoglobin levels 
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less than 9 gm% before iron supplementation was started and compliance 
rate was unsatisfactory in a considerable proportion of cases. This has 
been attributed to non delivery of the tablets to the women, poor quality 
of tablets, non consumption of tablets due lack of awareness about the 
importance of iron. 
 
Side effects of oral iron therapy are also mentioned as a reason for 
noncompliance, but these are probably more highlighted than real. It was 
also noted that as high as 38% of women who had consumed the tablets 
regularly for more than 90 days during the last trimester had hemoglobin 
levels less than 10 gm% and in 20% less than 9 gm%. It was felt that 60 
mg elemental iron is inadequate. So it was decided that prophylaxis 
programme should be converted into a control programme 
 
National Nutritional Anemia Control Programme 
The National Nutritional Anemia Control Programme was 
launched in 1991. Its objectives are: 
1. To assess the baseline prevalence of nutritional anemia in antenatal 
mothers and young children through estimation of hemoglobin 
levels. (Now it has been decided that severe anemia should be 
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identified clinically as hemoglobin estimation has limited utility 
and there is risk of spread of diseases). 
 
2. To put the mothers with more than 10 gm% and children with more 
than 8 gm% on the prophylaxis programme.  
 
3. To monitor continuously the quality, distribution and consumption 
of IFA tablets. 
 
4. To assess periodically the hemoglobin levels of the beneficiaries. 
 
5. To motivate the beneficiary mothers to consume the tablets through 
relevant nutritional education and pass on the information to their 
children. 
The target beneficiaries are 50% of total pregnant and nursing 
mothers 25% of total women acceptors of terminal methods and intra 
uterine devices and 50% of the total children between 1 and 3 years. 
Presently 27 million adults and 30 million child beneficiaries are covered 
under this programme. Also it has been made an integral part of CSSM 
programme. And now it is covered under RCH programme. 
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The recommended dosage: 
Pregnant women 
One big-(adult) tablet per day for 100 days, each tablet containing 
100 mg of elemental iron and 500 mcg of folate and these should be 
provided after the first trimester of pregnancy. 
 
Lactating women and IUD acceptors 
One big tablet for 100 days. 
 
Preschool children (1-3 years): 
One small (pediatric) tablet containing 20 mg of elemental iron and 
100 mcg of folic acid for 100 days every year. 
 
Constraints of the present strategy 
The recommended National Nutritional Anemia Control 
Programme advocating daily hematinic supplementation to pregnant 
women is not showing the expected results. These programmes have been 
ineffective, partly because side effects limit compliance, operational 
failures are the rule (eg, inadequate supplies and poor packaging and 
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presentation of supplements), and health workers and recipients lack 
appropriate information and motivation.3 
 
The major constraints being irregular availability of hematinics and 
lack of education and communication of the importance of hematinic 
supplementation during pregnancy leading to its poor compliance among 
subjects10-12. 
 
Alternate Strategies 
Strategies such as dietary diversification and food fortification 
have yield significant results in controlling iron deficiency anemia in 
developed countries. Reducing the prevalence of iron deficiency anemia 
in developing countries is still a matter of importance. Dietary 
diversification and food-based approaches pose considerable challenges 
before they can be implemented on a wide scale.13 
 
As the programmes did not show effective results in countries such 
as India, the dosage of iron was increased. Gastrointestinal distress 
(constipation, nausea, and diarrhea) are often experienced when 
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consuming iron supplements, especially on an empty stomach. Therefore 
chronic, daily use of iron supplements in excess should be avoided. 
 
There are a number of reports associating elevated iron stores with 
cardiovascular disease (CVD) and cancer. However, there are no studies 
that have associated specific chronic intake levels of dietary or 
supplemental iron with CVD and cancer. It is not possible to estimate 
how much iron must be consumed to result in a specific level of iron 
stores. 
 
The upper limit (45 mg/day) is for the general healthy population. 
Individuals with hemochromatosis may not be protected by the upper 
limit. Relative to an adult, the normal value for hemoglobin is high in 
neonates, falling to lower-than-adult values by 3-6 months, and rising 
gradually thereafter to the adult value by the early teenage years. The role 
of excess iron in causing intestinal oxidative stress has drawn attention to 
other approaches of iron supplementation. 
 
Prophylactic administration of iron along with antioxidants like 
vitamins E and C or foods rich in these vitamins is one such strategy. In 
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order to improve the compliance, reduce the cost of the therapy and 
reduce the intestinal oxidative stress schedules administering hematinics 
less than once daily have been tried. Gopalan C and Viteri FE in their 
studies have indicated that with continuous daily administration, iron 
absorption could decrease due to tiredness of the intestinal mucosa. 
 
According to a study, absorption from a single dose of iron reduces 
from 30 -40% on the first day to as low as 3-6% after a few days of 
continuous daily administration. Studies carried out on pre-schoolers 
support that iron supplementation once or twice a week, increase their 
hemoglobin status significantly. The potential benefits and shortcomings 
of these approaches are reviewed. 
 
In experimental animals, the absorption of supplemental iron is 
greatest when it is administered at times of intestinal mucosal renewal, so 
that each dose is received by new cell which is based on mucosal block 
theory. Thus, inhibition of iron absorption is minimized because of the 
iron overload in intestinal cells, which occurs with daily iron 
supplementation. 
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Because weekly supplementation with iron. is effective at 
improving iron status, this option should be thoroughly explored and 
evaluated in the context of programs for the prevention and the treatment 
of iron deficiency and anemia. 
 
Weekly supplementation programs may improve the logistical and 
economic constraints that currently limit the provision of supplements to 
the many target population groups for whom they are recommended, but 
usually fail to reach. Further work is required to clarify the purpose, 
delivery and outcomes of iron supplementation programmes. 
 
Technical Consultation by Human Nutrition Unitis 
In India, National Family Health Survey, documented that about 74 
percent children between the age of 6-35 months were anemic. A 
Technical Consultation was organized to discuss the Strategies for 
Prevention and Control of Iron Deficiency Anemia amongst under three 
children by the Human Nutrition Unit of the All India Institute of Medical 
Sciences, New Delhi on 17'h March, 2002. The consultation was 
sponsored by MOST-USAID Micro Nutrient Project, India. 
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The objectives of the consultation were: (1) to make 
recommendations for strengthening the child component of the National 
Nutritional Anemia Control Program (NNACP) and (2) to identify 
important researchable areas in this context. 
 
Conclusions and Recommendations by Human Nutrition Unit 
 
1. It is recommended that iron supplementation in the NNACP should 
be targeted to children in the age group of 6-35 months only. 
2. Ferrous sulphate is the least expensive iron compound. It is well 
absorbed, has reasonably good shelf life and has few side effects at 
dose levels used in the NNACP. 
 
3. The iron requirements for different ages are often defined in terms 
of body weight. However, in a community setting, it is not feasible 
to use this approach. Thus a simple fixed dose strategy rather than 
an exact dose based on a body weight basis is more appropriate for 
young children under the NNACP. With due consideration to the 
safety issues, it is recommended that 20 mg iron be used for anemia 
prophylaxis for all the children in this age group. The daily dosage 
of Iron Folio Acid (IFA) supplement (20 mg elemental iron + 100 
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mcg folic acid) recommended for children in the current on going 
NNACP is considered appropriate. 
 
4. Folic acid should be added to the iron supplements to prevent folio 
acid deficiency anemia. More scientific data is required on the 
magnitude of vitamin B12 and zinc deficiencies and the benefits of 
adding these micronutrients before their routine supplementation in 
conjunction with iron can be considered as public health 
intervention measure under NNACP. 
 
5. It is recommended that IFA supplementation should be done, daily 
for minimum of 100 days in a year. 
 
6. The IFA supplementation should be done through the peripheral 
village health and the ICDS functionaries.  
 
7. Promoting the consumption of, iron-fortified foods is an important 
approach to preventing anemia and this should be done wherever 
feasible.  
A brief overview of the iron metabolism and iron deficiency 
anemia will help in understanding alternate strategies. 
Iron Metabolism and iron deficiency Anemia  
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Iron deficiency anemia is the most common anemia in the world. 
The fourth most abundant element in the earth's crust, iron is only a trace 
element in biologic systems, making up only 0.004% of the body's mass. 
Yet it is an essential component or cofactor of numerous metabolic 
reactions. By weight, the great proportion of the body's iron is dedicated 
to its essential role as a structural component of hemoglobin. 
 
Without sufficient iron available to the RBC precursors, normal 
erythropoiesis cannot take place, and anemia develops. On the other hand, 
iron is a toxic substance. Too much iron accumulating in vital structures 
(especially the heart, pancreas, and liver) produces a potentially fatal 
condition, hemochromatosis. Iron is an essential component of the 
hemoglobin molecule, without iron the marrow is unable to produce 
hemoglobin. 
 
The red cell number falls and those which do reach the circulation 
are smaller than normal (microcytic) and lack hemoglobin, hence they are 
pale and under colored (hypochromic). The deficiency in iron may be 
absolute, that is, there is no iron available for the production of 
hemoglobin, this is true iron deficiency anemia. The deficiency may be 
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relative, that is, the iron is present in storage form in the marrow but is 
unavailable for hemoglobin production, and this is anemia of chronic 
disease. 
 
Iron distribution 
The majority of the iron is present as hemoglobin iron. 
Approximately 25% of the iron is maintained as storage iron (ferritin and 
hemosiderin) primarily in the bone marrow. 
 
- Hemoglobin   1.5 to 3.0 gm (65 to 70%) 
- Storage 
Ferritin &Hemosiderin  0.5 to 1.5 gm (20 to 30%) 
-Others 
 Myoglobin 
 Heme enzyme Remainder 
 
Iron absorption 
Iron absorption occurs primarily in the duodenum. Most of this 
iron is in the ferric form and is complexed to other organic and inorganic 
molecules. The acid in the stomach and hydrolytic enzymes in the small 
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intestine release the iron from these complexes. It is then reduced to the 
ferrous more readily absorbed in this state. Iron absorption is increased   
by the presence of glucose, some amino acids, ascorbic acid (Vitamin C). 
 
These substances aid in the absorption process by either reducing 
ferric iron to the ferrous state or by helping to bind the iron to the 
mucosal cell receptor sites. Heme iron, iron in meat myoglobin, is more 
easily absorbed than elemental iron. Iron absorption is decreased by the 
presence of phosphate, bicarbonate, bile acids. 
 
Once the ferrous iron (++) binds to receptors on the surface of 
mucosal cells, it is moved into the cell. This is an energy dependent 
process. in the mucosal cell the iron is oxidized back to the ferric state 
and bound to apoferritin in the cell. This continues until all the apoferritin 
bound at which point newly absorbed iron is no longer oxidized but rather 
is passed through the cell and into the portal circulation still in the ferrous 
state. In the blood, iron is bound to transferrin in the ferric state- Bound to 
transferrin, the iron is transported to the marrow for use or storage. 
 
Regulation of iron absorption 
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The intestinal wall is covered with villi, finger-like projections, 
which arc covered with absorptive mucosal cells. These cells are 
produced in the crypts of Lieberkhun, at the base of the villi, and move 
upwards to the villus tip to be desquamated (lost). Each cell is produced 
with a set amount of apoferritin. The more iron required- by the body the 
less apoferritin manufactured in each cell. In other words, it is the amount 
of apoferritin within each mucosal cell which acts as the gatekeeper and 
regulates the amount of iron absorbed. 
 
Iron transport 
Transferrin is the primary iron transport protein. It is a beta 
globulin and is produced in liver. It has a 1/2 life of 8-11 days. Each 
molecule of transferrin can bind and transport two molecules of iron in 
the ferric (++-+) state. Transferrin prefers to carry iron to the marrow but 
will carry iron to other organs if the marrow is damaged or excess 
amounts of iron are already stored in the marrow. In rare instances when 
transferrin is absent (atransferrinemia) other proteins can bind iron but 
carry the iron to other organs such as liver, spleen and pancreas, little if 
any is carried to the marrow. As well as specific receptors for iron, 
transferrin has specific receptors for sites on the developing normoblast. 
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Once bound to the cell membrane, the transferrin changes shape and 
releases the iron. It then returns to the portal circulation to bind more 
iron. Under normal circumstances approximately 1-3% of the transferrin 
has iron bound to it. 
 
Iron transfer across the Red Cell membrane 
Iron can be transferred to developing red cells either bound to 
transferrin or presented as ferritin to the developing cells as they cluster 
around "nurse Cell" RE cells. The iron is moved into the developing red 
cell. Clusters of normoblast around a nurse cell are called a "feed island." 
 
Iron Storage 
Iron is stored as either ferritin or hemosiderin; ferritin consists of 
an outer protein shell with iron complexes within the core. The outer shell 
consists of 22 apoferritin molecules while the core consists of an iron 
phosphate complex consisting of 4,000 to 5,000 molecules of iron in each 
core. Ferritin is water soluble and a very small amount is dissolved in 
plasma. 
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The ferritin reference range for males is 15-200 ng/ml, 12 to 150 
ng/ml for females and for children 6 months to 15 years is 7-140 mg/ml. 
Ferritin is not visible by light microscopy, nor is it stained by the Prussian 
blue reaction, Hemosiderin is aggregated ferritin molecules. The protein 
shell has been altered and as a result it is water insoluble. It can be seen 
by light microscopy as gold-brown granules and is demonstrated by the 
Prussian blue stain. 
 
Daily Iron Requirements 
The adult male requires approximately 1.0 mg/day, just enough to 
cover normal iron loss. The adult female requires approximately 2.0 
mg/day, enough for daily loss and menstruation. Pregnant females require 
approximately 3.0 mg/day, enough for normal, on going loss and fetal 
requirements. Children require approximately 2.0 mg/day, enough for 
normal loss and extra to produce some residual iron stores and allow for 
increasing red cell mass. 
 
 
 
Causes of Iron Deficiency 
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Failure in absorption of iron. 
Increased utilization.  
Pregnancy   
Adolescent growth  
Atransferrinemia 
Failure to utilize 
Lead poisoning  
Chronic diseases  
Blood loss  
 
Chronic blood loss is an important cause of iron deficiency anemia 
particularly in older children. 
 
Development of Iron Deficiency Anemia. 
 It must be remembered that anemia in iron deficiency develops 
slowly. The type and severity of the anemia varies with time. 
 
Development Stages:  
1. Depletion of iron stores, decreased ferritin levels, no anemia. 
2. Increased transferrin levels, no anemia. 
3. Fall in serum iron, no anemia. 
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4. Development of normocytic, normochromic anemia. 
5. Development of microcytic, hypochromic anemia. 
 
 The clinical manifestations vary with the age, degree and rapidity of 
onset and other factors. Mild anemia is often asymptomatic. The main 
symptoms are exercise dyspnea, fatigue, palpitation, pica (consumption of 
substances such as ice, starch or clay, frequently found in iron deficiency 
anemia), syncope (particularly following exercise) and bounding, pulse. 
Dizziness, headache, syncope, tinnitus or vertigo, irritability, difficulty in 
sleeping or concentrating are more frequent in severe chronic anemia. 
Plasma ferritin level was significantly lower in children with first febrile 
seizure suggesting a possible role for iron insufficiency in first febrile 
seizures. 
 
Common signs are pallor (color of skin, palms, oral and 
conjunctival mucous membrane and nail beds), tachycardia, ejection 
systolic murmur, mild peripheral edema and venous hums and wide pulse 
pressure. In old people, angina pectoris can be an important clinical 
manifestation. 
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Cardiovascular Adaptations in Anemia 
The main consequence of anemia is tissue hypoxia. If anemia has 
developed rapidly, there may not be adequate time for compensatory 
adjustments to take place, so there is a sudden marked contraction of 
intravascular volume, resulting in postural hypotension, fall in cardiac 
output, shunting of blood from skin to central organs, sweating, 
restlessness, thirst and air hunger. If anemia occurs slowly, many 
adaptations occur for the oxygen maintenance, such as increasing of 
plasma volume and right shift of the oxygen-hemoglobin dissociation 
curve.   
 
Laboratory Diagnosis of Iron Deficiency 
Routine procedures 
Hb, Hct and RBC count are all decreased. The degree of decrease 
depends upon the length of time the marrow has been without sufficient 
supplies of iron. It must be remembered that at any stage the red cell 
number will not be proportionately as low as is the Hb and Hct. This is 
due to the fact that the marrow can continue to produce cells which are 
deficient in hemoglobin. 
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Red Cell Distribution Width  : (RDW) is increased in iron deficiency 
anemia.  
 
Special procedures  
A bone marrow examination is seldom, if ever, performed or 
needed for the diagnosis of an iron deficiency anemia. If however, a bone 
marrow is performed the following results would be present. 
 
Bone Marrow 
Cellularity - normal to increased. 
Morphology - normoblastic with some dyserythropoiesis. Ragged 
reduced cytoplasm, vacuoles, multinuclearity, karyorhexis, nuclear 
budding, abnormal mitosis. All these may be seen but are not the 
predominant features of the marrow. Iron stain - absent. The absence of 
iron is considered to be the "gold standard" for the diagnosis of iron 
deficiency. 
 
The other findings are: 
Siderocytes - absent.  
Serum iron - decreased.   
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TIBC – increased 
 % saturation - decreased. 
 Ferritin - decreased.  
Free erythrocyte protoporphyrin (FEP) - increased. 
Treatment 
Iron supplementation is the main stay of treatment. The response is 
monitored with the reticulocyte count, hemoglobin and hematocrit. 
Responses to iron therapy in iron deficiency anemia 
Time after iron Response 
administration  
12-24 Hrs Replacement of intracellular iron enzyme, 
 subjective improvement, decrease in  irritability, 
 increase in appetite. 
36-48 Hrs. Initial bone marrow response; erythroid 
 hyperplasia 
48-72 Hrs. Reticulocytosis, peaking at 5-7 days. 
4 -30 Days Increase in hemoglobin levels. 
1 - 3 Months Repletion of iron stores. 
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Iron treatment should be continued for 8 weeks after blood values are 
normal to replace the stores. 
Failure to respond may be due to:  
1. Continued bleeding  
2. Failure to take iron  
3. Wrong diagnosis  
4. Mixed deficiency  
5. Other causes – inflammation  
6. Malbsorption – less likely    
 
In 1832, ferric carbonate bills were introduced and called as 
Blaund’s pill. Other iron formulations are ferrous sulphate, ferrous acetate, 
ferrous ascorbate etc.,  
 
Recommended dosage of ferrous sulphate tablets in treatment of 
Iron deficiency anemia is 3 to 6 mg/kg/day.  
 
A randomized control trial by Sachdev13 on directly observed iron 
therapy in rural population in Reva district Madhya Pradesh concluded 
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that outcome of oral iron therapy was influenced in a majority by gastro 
intestinal side effects of iron therapy.  
 
Studies propose that even with good compliance of iron 
supplementation, a considerable proportion of the people have not 
improved. A list of reasons have been proposed for the failure of oral iron 
supplementation. The leading causes are deficient caloric intake, 
associated poor nutritional status, low birth weight, gastrointestinal side 
effects and any intercurrent infections like recurrent pneumonia, acute 
gastroenteritis  etc..,  
 
When good compliance itself is a rare happening, these factors are 
like a hurdle in these cases. So finding out the role of these factors in the 
out come of oral iron therapy is important for the betterment of the 
children.  
   
 
 
 
 
 
 
 
 
 
 
LITERATURE 
REVIEW 
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LITERATURE REVIEW 
 
Despite the advances in scientific knowledge regarding various 
causes, treatment and various potential strategies for controlling 
micronutrient deficiencies, iron deficiency anemia, Vitamin A deficiency 
and iodine deficiency remain significant public health challenges for 
growing children and adolescents. Childhood anemia continues to be 
significant health problem and iron deficiency is the commonest 
nutritional cause of anemia.  
 
While iron supplements are needed in certain groups of children 
and in particular regions, increased dietary calorie intake could be 
supplied by food fortification as well as by individual improvements in 
intake.  
 
In an article published by Papagallo S, on the operational problems 
of an iron supplementation programme for adolescents and children by 
UNRWA (UNITED NATIONS RELIEF AND WORK AGENCY) he 
said routing iron supplementation for children and adolescents should be 
coupled with additional interventions like increasing dietary calories 
intake, improving dietary habits etc.,14   
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STUDIES REGARDING VARIOUS ASPECTS INTERFERING IN 
THE SUPPLEMENTATION AND ITS EFFECTIVENESS 
 
 Thompson et al in june 2002 conducted a study at Middleton that 
L.B.W children had inadequate response with oral iron therapy when 
compared with normal birthweight in age group 1 to 10 yrs15.   
 
 RCT on directly observed iron therapy in rural population done in 
M.P. Reva district concluded that outcome of oral iron therapy was 
influenced in a majority by gastrointestinal side effects of oral iron 
therapy.  
 
 On the role of caloric supplementation in prevention and control of 
iron deficiency anemia in children Madhavan Nair et al have shown 
that calorie supplementation is very important in the success of oral 
iron therapy in the treatment of iron deficiency anemia10.  The study 
concluded that the children who were deprived of expected calories 
for that age had difficulty in improving their hemoglobin level 
inspite of good compliance of oral iron therapy. 
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 Chinese study done by Gillespie (1998) has shown that children who 
were given additional greens and non vegetarian diet improved well 
in Hemoglobin status in a randomised control trial12.  
 
 Buerger Nicholson et al (1997) in their study proposed that low birth 
weight children and preterm children, who were anemic, had 
difficulty in improving when compared to term , AGA children3.  
 
  
 
 
 
 
 
 
 
 
STUDY 
JUSTIFICATION 
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STUDY JUSTIFICATION 
Iron deficiency anemia is the most common nutritional deficiency 
disorder in the country National Nutritional Anemia  Control Programme 
covers children <36 months of age and adolescent girls. Anemia control 
programme covers adolescent girls for the control of anemia. All such 
programmes are present here for years, but anemia is still found to be a 
main problem in the health of the people.  
 
Anemia has drastic ill effects on children like defects in immunity 
and defence mechanisms, infections, failure to thire, poor scholastic 
performance etc.,  Therefore, it has to be promptly managed.   
 
Oral iron therapy is usually the first line management in treating 
iron deficiently anemia using ferrous sulphate tablets with folic acid. 
Ideally, the hemoglobin levels should improve by 1 to 2 months. But it 
has not happened regularly, as suggested by previous studies, even with a 
good compliance of drugs.  
 
So, what is the cause for the failure? This study has been done with 
a view of finding out those factors, which are a main hurdle, in anemia 
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treatment and their role in causing problems at effective improvement 
when there is a good compliance.    
 
 Finding those factors, whether they have an impact, will help those 
vulnerable children to recover from anemia by management of those 
conditions and formulation of alternate strategies in such children.  
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AIM OF THE STUDY  
 
 
To study the effectiveness of oral iron therapy in childhood 
nutritional anemia and factors affecting the outcome, in the age group of 
1 to 5 years.    
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MATERIALS AND METHODS 
 
Hypothesis of the study is that various factors play a role in 
outcome of oral iron therapy.  
 
The study group involved in this study were those children who 
were referred to the nutrition out-patient department at Institute of child 
health, with hemoglobin less than 11gm % in the age group 1-5 years and 
with a peripheral smear showing microcytic hypochromic RBCs with 
anisopoikilocytosis.  
 
The parents of the children or guardian were informed about the 
study and informed consent was obtained from them. This study was 
started in Jan 2009 and conducted upto June 2010 for a period of one and 
a half years.  
 
EXCLUSION CRITERIA:  
1. Lymphoreticular malignancy – blast cells in P.Smear  
2. Hemolysis – increased reticulocyte count and other studies 
confirming hemolysis.  
3. Pancytopenia, thrombocytopenia  
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4. Congenital heart disease / congestive cardiac failure  
5. Hypersegmented WBCs, nucleated RBCs in P.smear 
6. Hemoglobin < 4gm% needing blood transfusion  
7. Gastritis, persistent vomiting  
8. Bleeding manifestations, Jaundice  
9. HIV infected children  
10. Those who miss atleast 2 weeks of treatment in the 2 months of 
study.  
11. Those who received any oral iron treatment in last 2 months / on 
any long term treatment.  
 
Those who fulfilled the inclusion criteria participated in the study.   
 
Under aseptic precautions, two ml of venous blood sample was taken 
from each child and sample was sent to laboratory for Hb% estimation, 
using cyanmethemoglobin method and reticulocyte count. EDTA 
(Ethylene Diamine Tetra Aceticacid) was used as anticoagulant.   
Peripheral blood smear was taken from each of them. Stool sample was 
sent to rule out any occult blood loss and worm infestation.   
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Each child’s clinical history and examination were entered in the case 
proforma, which also had a questionnaire for the parents to answer, 
regarding various factors in the follow up visits. The results of the 
investigation were entered in the proforma.  
 
Weight of the child, in kg, with a sensitivity of 100gm was recorded 
using standard weighting machines. Each child was weighed naked or 
with minimal clothing with no shoes. Weight for age, was assessed per 
IAP classification of malnutrition. Length of  each child less than 2 years 
was measured using an infantometer to the nearest 0.5cm. Height of the 
children 2 years and above was measured using a stadiometer to the 
nearest 0.5cm. The child was asked to be bare footed and with chin 
straight along Frankfurt plane. Data were entered in proforma.  
   
Each child at the start of the  study was dewormed with a tablet of 
albendazole 400 mg and children less than 2 years of age were dewormed 
with albendazole 200mg.  Then the parents were given 3mg / kg of 
ferrous sulphate tablets with folic acid, to be given to the child.   Tablets 
were supplied by the Hospital for 2 weeks and they were instructed to 
come back after 2 weeks to collect the tablets. They were advised to give 
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the tablets with water, more than one hour after food and never in empty 
stomach.   
 
Nutritional advice was given to increase calorie intake, if it was 
less than expected. Dietary advice was given to include iron rich foods. 
 
Contact address and phone number of the principal investigator 
was given to the parents. At the end of the visit after  1st and 2nd months, 
the same laboratory investigations were repeated.  
 
At each of 1st and 2nd visit, a predesigned questionnaire was given 
to the parents and was filled up by them regarding the factors expected to 
have an impact on the improvement of the Hb%. Results of the 
investigations at end of the 1st visit,  at end of 1st and 2nd month were 
tabulated, compared and analysed. The answers of the questionnaire were 
also analysed.   
 
Daily dietary caloric intake of the child was recorded from the 24 
hr recall of the parent at the end of 1st and 2nd month. Dietary caloric 
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intake as against the ICMR recommendations as expected for that age 
was calculated and entered.  
 
Those who reached 11g % of Hb were considered as controls and 
those who did not as cases. Both groups were compared about various 
variables from the answered questionnaires and analysed.   
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ANALYSIS OF OBSERVATIONS 
 
 Totally 117 children took part in this study. Out of them 101 
completed the 2 months period of study. 16 of them dropped out during 
the study period.  
 
Minimum age of children in this study was 1 ½ years and 
maximum was 5 years and the mean age was 3.4 years. 60% of the 
children were in the age group of  3 to 4 ½ years.  
 
 67 boys and 50 girls took part in the study. In those children, 16 
boys dropped out during the study period. Totally 51 boys and 50 girls 
were present thoughout the study.  
 
  Only 60 children out of 101 children, had regularly consumed the 
tablets, daily with good compliance, as per the records perused and also 
on the basis of questionnaires filled by the parents.  41 children didnot 
take tablets daily. They had some remaining tablets regularly during the 
visits. Out of these 60 children who had regularly taken the iron tablets, 
only 51 children reached a Hb level of the 11gm % and 9 children did 
not. 
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41 children who did not consume tablets daily as per the advice, 
given by the investigator did not improve to reach a Hb level of 11gm %.  
9 children (15%) did not improve even with a good compliance. 51 out of 
60 children (85%) who took the tablets regularly improved to reach a Hb 
of 11gm %. These 51 children were considered as controls, and 9 children 
who did not improve to reach a Hb of 11gm% were considered as cases. 
Both groups were compared about various factors, causing the difference 
and the results are as follows:  
 
 
51 children improved to reach a Hb level of 11 gm % they were 
considered  as controls. 9 children did not improve and they were 
considered as cases. 
 
Hb Outcome Tablets taken 
daily 
Tablets not 
taken 
daily 
Total 
Those 
achieving 
Hb<11 gm% 
9 (15%) 41 (100%) 50 
Those 
achieving 
Hb>11 gm% 
51 (85%) - 51 
   101 
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Weight for age (% of expected)  
 Out of 9 cases who did not improve, 7 had grade III and IV PEM 
(77.7%) These children weighed less than 60% of expected for that age. 3 
out of 51 controls (5.8%) had a weight of less than 60% expected for that 
age.  48 out of 51 controls (94.2%) weighed more than 60% expected for 
that age (grade I, II PEM and normal)  
 
Hb Outcome 
Weight for age 
Total 
<60% >60% 
Cases (Hb<11) 7 (77.2%) 2 (22.2%) 9 
Controls 
(Hb>11) 
3 (5.8%) 48 (94.2%) 51 
   60 
 
P value = 0.000 (significant)  
Caloric intake:  
 All the children were given nutritional advice; even then some 
children were not given the required calories for that age, which was 
based on dietary assessment at the end of first and second month. All the 
9 cases had <75% calorie intake expected for that age and none of them 
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reached the target of Hb 11gm% 4 out of 51 controls (7.8%) had <75% 
calorie intake expected for that age. 47 out of 51 controls (92.2%)  had 
>75% of calorie intake expected for that age.  
Hb Outcome 
Calorie Intake expected for that 
age   Total 
<75% >75% 
Cases (Hb<11) 9 (100%) 0 (0%) 9 
Controls 
(Hb>11) 
4 (7.8%) 47 (92.2%) 51 
   60 
p = 0.000 (significant)    
Birth weight:  
 Children who were less than  2.5kg at birth were considered LBW 
children. 6 out of 9 cases were <2.5 kg at birth (66.6%).  7 out of 51 
controls (13.7%) were less than 2.5kg at birth. 86.3% of the controls  
were more than 2.5kg at birth.   
Hb Outcome 
Birth weight  (in kg) 
Total 
<2.5 >2.5 
Cases (Hb<11) 6 (66.6%) 3(33.3%) 9 
Controls (Hb>11) 7 (13.7%) 44(86.3%) 51 
   60 
p = 0.040 (significant) 
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ANALYSIS REGARDING TABLETS INTAKE:  
 Out of 51 controls, 40children(78.4%) never had the tablets in 
empty stomach and consumed it more than one hour after food intake. 5 
out of 51 controls (9.8%) consumed the tablets in empty stomach. 6 of the 
51 controls (11.8%) consumed the tablets within 1 hour of food intake.  
 5 out of 9 cases consumed tablet in empty stomach (55.5%) 4 out 
of 9 cases (44.4%) consumed the tablets within one hour of food intake  
 P = 0.020 (significant)  
 
 
 Out of 51 controls ,34 children (66.6%)did not consume tea/milk 
with tablets.17 out of 51 controls(33.3%)consumed tea/milk with 
tablets.5 out of 9 cases(55.5%) consumed tea/milk with tablets. 
Hb Outcome 
Tea / Milk with tablets   
Total 
Yes No 
Cases (Hb<11) 5 (55.5%) 4(44.4%) 9 
Controls 
(Hb>11) 
17 (33.3%) 34(66.6%) 51 
   60 
p = 0.000 (significant) 
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 34 children of 51 controls(66.6%) consumed lime / curd / orange 
after food. All the  9 cases(100%) didnot consume.  
Hb Outcome 
Lime/curd/orange with food   
Total 
Yes No 
Cases (Hb<11) 0 34 (66.6) 9 
Controls 
(Hb>11) 
9(100%) 17(33.3) 51 
   60 
p = 0.020 (significant) 
 Out of 9 cases, 6 cases (66.6%) had atleast 1 episode of                
LRI /gastroenteritis / hospitalization.  3 cases did not have such a history. 
Out of 51 controls,only 11children(21.6%) had such a history.  
Hb Outcome 
LRI / Gastroenteritis/ 
hospitalisation>= 1 episode Total 
Yes No 
Cases (Hb<11) 6 (66.6%) 3(33.3%) 9 
Controls 
(Hb>11) 
11 (21.6%) 40(79.4%) 51 
   60 
 
P = 0.000 (significant)  
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None of the 51 controls and 9 cases had occult blood in stools,by 
stool examination. All children were dewormed at the start of study.  
None of the cases or controls complained of worms in stools during the 
study period.2 out of 51 controls and 7 out of 9 cases experienced 
vomiting / stomachache / constipation   
 
All datas were tablulated and analysed  by using  SPSS, SAS 
software.   
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DISCUSSION 
Nutritional deficiency disorder contitues a major health problem in 
India. In India, 74% of children have anemia according to NFHS survey. 
Among the micronutrients, iron is one of the most important for the 
body’s well being.  
 
This study has shown that there is a major setback in the 
compliance. About 40% of children who completed the study were not 
given tablets daily. There were remaining tablets at each of the visit. The 
reasons as derived from the questionnaires are side effects like vomiting, 
stomachache, constipation etc., More over, these children took the tablets 
in empty stomach and didnot follow the advice given at the start of study 
by the investigator. Parents have to be still taught more about the 
importance of giving the tablets regularly and as prescribed, as to avoid to 
ill effects of anemia and to minimize side effects of iron.  
 
In an article published by Papagallo S, on the operational problems 
of iron supplementation programme for adolescents and children, by 
UNRWA (UNITED NATIONS RELIEF AND WORK AGENCY), he 
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said that iron supplementation, could be successful, when it is combined 
with increasing dietary caloric intake and changing dietary habits14.  
 
In this study also, the same thing is reflected. Among the children 
who had regular intake of tablets, but were taking <75% of calories 
expected for that age and not taking greens and vegetables in food, did 
not reach the target of Hb 11gm%.  
 
Madhavan Nair et al10, in his study titled, “Prevention and control 
of iron deficiency anemia in children – Role of caloric suppplementation” 
– proposed that caloric deprivation will be an obstacle for child who is 
being treated for anemia.  In this study also, 9 cases who didnot improve, 
were taking <75% of calories as expected for that age and only 8% of 
controls were taking <75% of calories as expected for that age. 
 
Thomson et al in Minesotta, U.S.A. conducted a study in 1- 10 yrs 
old children, who were anemic and said that birth weight was a major 
determinant in outcome. Low birth weight children had a difficulty in 
improving15.  This study also supports the same. About 66% of the 9 
cases were less than 2.5kg at birth and only 13.7% of 51 controls had a 
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birth weight of less than  2.5kg.  Buerger Nicholson et al (1997) also 
made similar observation. 3  
   
A randomized control trial done by Sachdev13, on directly observed 
iron therapy in Reva District, Madhya Pradesh concluded that the 
outcome was influenced by gastrointestinal side effects. In this study 
also, 7 out of 9 cases who did not improve, had complaints of vomiting / 
stomachache / constipation after tablets intake. 
 
About 78% of the cases weighed <60% expected for that age (PEM 
grade III & IV. But only 5.8% of the controls weighed <60% expected for 
that age. It suggests that nutritional status of the child is very important in 
improvement of Hb status during oral iron therapy. 
 
Intercurrent infections also may play a role in iron absorption or 
utilisation History of any hospitalization or loose stools or ARI was a 
strong factor in deciding the outcome. 40 out of 51 controls who 
improved, did not have any history of the same, while 6 of 9 cases has 
experienced the same.  This suggests that frequent infections may be a 
factor in non-improvement despite regular iron intake. 
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There was no complaint of worms in stools due to prior deworming 
in any of the 60 children who regularly took the tablets, in the 2 months 
of study period.  
 
 There was no fecal blood loss in any of the 60 children who 
regularly consumed the tablets daily in the 2 months of study 
period. 
 About 33% of the controls and 55% of the cases consumed 
tea/milk with the tablets. 
 About 35% of controls, and all 9 cases didnot consume 
curd/lime with food intake.  About 65% of children who 
improved, had consumed curd/lime with food intake. 
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Limitations of the Study : 
 
 The sample size is small, especially in the control group.   
(children who did not improve despite optimal oral iron 
therapy). 
 Thalassemia trait, which is one of the causes for non 
improvement in Hb status was not determined in the study. 
 Parental education or socio-economic status was not compared. 
  
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
 
 The compliance with oral iron therapy was about 60%.  85% of the 
children who were totally compliant improved to reach the target 
hemoglobin level.  15% of the children who were totally compliant 
did not improve. 
 
 The factors for non improvement in Hb status in those who were 
totally compliant are LBW, malnutrition, suboptimal caloric intake 
and frequent infections. 
 
 Anemic children who had a low birth weight had a difficulty in 
improving their hemoglobin level. Children who had a normal birth 
weight improved well. 
 
 One has to be more concerned about the respiratory tract infection 
and gastroenteritis in anemic children. Prompt treatment is needed 
for these conditions and counseling on diet during and after the 
illness is essential. 
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 Malnourished children (PEM 3,4) have to be still more aggressively 
treated for anemia along with nutritional rehabilitation. Nutritional 
status of the child is an important factor in improvement of anemia. 
Dietary advice has to be effective and one has to make sure that the 
child gets enough calories expected for its age.  
 
 Consumption of greens and vegetables should be encouraged in 
children treated for anemia.  
 
 It is better to avoid tea or milk after food. Curd or citrus fruits intake 
can be encouraged after food. 
 
 Parents have to be counseled better about the ill effects of anemia. 
They have to be aware of giving the tablets daily, never in empty 
stomach and more than one hour after food intake. The drug 
compliance has to be made better and counseling has to be done to 
reduce the side effects. 
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ANNEXURE I  
QUESTIONNAIRE  
NAME :   AGE:  SEX:  OP/IP NO:  
DATE:   HEIGHT/LENGTH –  
      AT 1 MONTH  
      AT 2 MONTHS  
   WEIGHT:  
     AT 1 MONTH:   
     AT 2 MONTHS:  
 
H/O AND CLINICAL ASSESSMENT: 
C/O-  
 
YES/NO 
SOIL EATING – 
BREATHLESSNESS- 
FATIGUE- 
PALPITATION- 
ANOREXIA- 
ICE EATING-  
 
PAST H/O-  
CONTACT WITH TB CASE-  
FAMILY H/O  
DEVELOPMENTAL H/O-  
EXAMINATION-     YES/NO  
 DYSMOPHIC FACIES- 
 PALLOR –  
  57
 JAUNDICE- 
 LYMPHADENOPATHY- 
 EDEMA- 
 HAIR/SKIN CHANGES-  
DIAGNOSIS-  
 
INVESTIGATIONS:  AT FIRST VISIT 1 MONTH 2 MONTHS  
Hb%  
CAC – MCV  
MCHC 
MCH 
PCV 
RDW 
RBC COUNT  
S.FERRITIN  
PERIPHERAL SMEAR 
RETICULOCYTE COUNT  
FECAL OCCULT BLOOD 
BIRTH WEIGHT: 
BREAST FED/NOT:  IF NO, WHAT MILK THEN:  
WEANING AT   MONTHS OF LIFE  
H/O EATING SOIL/ICE ETC: YES/NO:  
H/O RED COLORED STOOLS: YES/NO: 
H/O WORMS IN STOOLS YES/NO:  DEWORMING:  
H/O LONG STAY IN HOSPITAL YES/NO:  
IF YES, FOR WHAT: 
H/O > 1 EPISODE PER MONTH OF LOOSE STOOLS/ ARI:  
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AVG USUAL DIET-   AMOUNT  CALORIES  
MORNING  
 
NOON 
 
EVENING  
 
NIGHT  
 
WEEKLY FEED OF GREEENS : FREQ: QUANTITY
    NON VEG:  FREQ: QUANTITY: 
DO YOU GIVE ANY OF THE FOLLOWING SOON AFTER A 
MEAL?  
TEA  
MILK  
LEMON / ORANGE JUICE / CURD:  
   MONTH 1    2 
DID YOU GIVE THE TABLETS DAILY? YES/NO:  
ANY PROBLEM IN GIVING TABLETS-  
WHETHER TAB WAS TAKEN IN EMPTY STOMACH:  
WITHIN 1 HR OR > 1 HR OF MEAL:  
TABLETS COUNT AT END OF WEEKS  2 4 6 8  
 
H/O NO OF LOOSE STOOLS/AR1:IN LAST MONTH-  
ANY HOSPITALISATION/HOSPITAL VISIT:  
H/O VOMITTING/STOMACHACHE: 
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WHETHER ANY OF THE FOLLOWING GIVEN SOON AFTER 
MEAL:  
TEA / MILK   
LEMON/ORANGE JUICE / CURD  
WHETHER GREENS / NON VEG GIVEN > THAN USUAL DIET:  
 
ANY DEWORMING DONE:  
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ANNEXURE II 
 
INFORMED CONSENT FORM 
 
I,      FATHER/MOTHER/GUARDIAN 
OF        AGED  BOY/GIRL 
WAS INFORMED BY THE DOCTOR THAT MY CHILD IS 
SUFFERING FROM ANEMIA AND THAT BLOODS SAMPLES AND 
STOOL TEST WILL BE TAKEN IN ASEPTIC CONDITIONS TO 
CONFIRM THE DIAGNOSIS. 
 
 HE TOLD ME THE CONSEQUENCES AND ILL EFFECTS OF 
ANEMIA. AND THAT THE INVESTIGATIONS WILLBE TAKEN AT 
FREE OF COST.  
 
 1, THERFORE AGREE TO GET MY CHILD PARTICIPATE IN 
THIS STUDY WITH MY OWN KNOWLEDGE. I WILL PROVIDE 
CORRECT INFORMATIONS NEEDED.  
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Informed consent form. 
I ..................... father/ mother/ guardian of the under mentioned child do 
hereby agree and allow my daughter/son/ward to participate in the study.  
2. I confirm that I have been told about this study in my mother tongue and 
have had the opportunity to ask questions.  
3. I confirm that i have been told about the risk and poetntial benefits for my 
Child’s/ward’s participation in this study.  
4. I understand that my child’s/ward’s participation is voluntary and I have 
the right to withdraw my child/ward from this study at any part of time 
with out giving any reasons and with out my child’s / ward’s benefits 
being affected.  
5. I agree not to restrict the use of any data or results that my arise from this 
study.  
Name and age of the child/ward 
Name and address of the father/mother/guardian 
 
Name and address of the Witness  
(prefer a person not involved in this study)   
 
Name and address of the Investigator  
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ANNEXURE – III 
 
CYANMETHEMOGLOBIN METHOD: 
 It is the WHO recommended method for determining Hemoglobin 
concentration.  
 Basis of the method is dilution of blood in a solution containing 
potassium cyanide and potassium ferricyanide. Hemoglobin, 
methemoglobin, Carboxy hemoglobin but not sulph Hemoglobin are 
converted HiCN. The absorbance of solution in then measured in 
spectrometer at a wavelength of 540mm or photoelectric calorimeter 
with  a yellow green filter.  
 
Diluents: 
 Drabkins cyanide ferricyanide solution with PH of 7.0-  7.4  
Potassium ferricyanide   (0.607mmol/1) 200 mg  
Potassium Cyanide   (0.768mmol/1)   50 mg  
Potasium Dihydrogen phosphate(1.029mmol/1) 140 mg    
Non ionic detergent             1 ml   
Distilled or deionized water            1 Litre    
 
Method:  
 
 Make a 1 in 201 dilution of blood by adding 20ml blood to 4 ml of 
diluents. After being allowed to stand at room temperature for atleast 5 
min, pour test sample to current and read absorbance in spectrometer at 
540 nm or in a photoelectric calorimeter.  
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Advantages:  
 
1. It allows direct comparison with HiCN standard after dilution, so 
batching is possible.  
 
2. All forms of Hb,except SHb are converted to HiCN.   
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